1. Exit Case: Bausch Health Companies Inc. 

Overview:

Bausch Health Companies Inc. (TSX: BHC) is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology.

BHC has been a part of the ‘Growth Portfolio’ since 18^th September 2025, however, considering the recent attempt to break above CAD 10—a level the stock failed at multiple times last year and was rejected again. Moreover, the sharp upper wick near CAD 10 suggests sellers are still in control at that level. Hence an ‘Exit’ is recommended from the stock at the last closing price of CAD 9.48, as on 8^th December 2025.  

1.1 Support and Resistance Summary as provided in our last published report dated 18^th September 2025.

Bausch Health Companies Inc.

2. New Entry Case: Kincora Copper Limited 

Overview:  

Kincora Copper Limited (TSXV: KCC) is a mineral exploration company. The company is engaged in the acquisition and exploration of exploration and evaluation assets in Mongolia. It operates in Kincora's dominate position between and on strike from the two existing copper mines in the Southern Gobi.

Technical Analysis: On the daily chart, KCC shows improving strength as it rebounds from recent lows, holding above key support with renewed buying interest. The RSI is curling upward, signaling momentum recovery, while price begins to stabilize near the 14-day SMMA. Earlier strong spikes demonstrate buyers’ ability to drive sharp upside when volume returns. The key support for stock is at CAD 0.82, while the critical resistance level is at CAD 1.14.

Considering the above mentioned factors, technical analysis, support & resistance levels, an ‘Entry’ is recommended in the ‘Growth Portfolio’ at the closing market price of CAD 0.97, as on 8^th December 2025. 

2.1 Support and Resistance Summary (as on 8^th December 2025)

2.2 Kincora Copper Limited

Note 1: Past performance is neither an Indicator nor a guarantee of future performance.

Note 2: The reference date for all price data, and currency as of 8^th December 2025). The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings.

Disclaimer

This information should not be relied upon as personal financial advice by Kalkine on (i) the stocks or (ii) the use or suitability of the model portfolios. Only an investor knows about their circumstances to make an investment decision.

Model Portfolio has been prepared for illustrative purpose only and does not take into account the objectives, financial situation or needs of any particular investor. Accordingly, investors should, before acting on the information, consider its appropriateness, having regard to their objectives, financial situation and needs. Past performance is not necessarily indicative of future performance results. Actual investment returns will vary, and the value of investments can go up or down.